Intellia Therapeutics, Inc. (NTLA)

CIK 1652130 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Intellia Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Nov 5, 20268-K0001193125-26-448673
Nov 5, 202610-Q0001193125-26-449862
Nov 3, 202640001193125-26-445417
Nov 2, 20261440001969223-26-001116
Oct 28, 202630001193125-26-436123
Oct 28, 202640001193125-26-436131
Oct 6, 202640001193125-26-415541
Oct 5, 20261440001950047-26-010054
Sep 8, 20268-K0001193125-26-385194
Sep 4, 20268-K0001193125-26-383645
Aug 24, 202640001193125-26-363567
Aug 20, 20261440001969223-26-000938
Aug 7, 2026SCHEDULE 13G0000093751-26-000484
Aug 6, 20268-K0001193125-26-336772
Aug 6, 202610-Q0001193125-26-337952
Jul 24, 202640001193125-26-316279
Jul 6, 202640001821530-26-000002
Jul 6, 202640002019493-26-000002
Jul 2, 20261440001950047-26-006836
Jun 15, 20268-K0001193125-26-270358
Jun 10, 202640001193125-26-266230
Jun 10, 202640001563572-26-000001
Jun 10, 20268-K0001193125-26-265934
Jun 10, 202640001193125-26-266241
Jun 10, 202640001193125-26-266233